BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34558604)

  • 1. IMB-BZ as an Inhibitor Targeting ESX-1 Secretion System to Control Mycobacterial Infection.
    Jia P; Zhang Y; Xu J; Zhu M; Peng S; Zhang Y; Zhao J; Li X; Mi K; Yan D; Wang Y; Yu L; Lu Y; Shi H; Cen S
    J Infect Dis; 2022 Feb; 225(4):608-616. PubMed ID: 34558604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium tuberculosis Toxin CpnT Is an ESX-5 Substrate and Requires Three Type VII Secretion Systems for Intracellular Secretion.
    Izquierdo Lafuente B; Ummels R; Kuijl C; Bitter W; Speer A
    mBio; 2021 Mar; 12(2):. PubMed ID: 33653883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein Synthesis and Degradation Inhibitors Potently Block
    Drever K; Lim ZL; Zriba S; Chen JM
    ACS Infect Dis; 2021 Feb; 7(2):273-280. PubMed ID: 33534536
    [No Abstract]   [Full Text] [Related]  

  • 4. ESX-3 secretion system in Mycobacterium: An overview.
    Granados-Tristán AL; Hernández-Luna CE; González-Escalante LA; Camacho-Moll ME; Silva-Ramírez B; Bermúdez de León M; Peñuelas-Urquides K
    Biochimie; 2024 Jan; 216():46-55. PubMed ID: 37879428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting type VII/ESX secretion systems for development of novel antimycobacterial drugs.
    Bottai D; Serafini A; Cascioferro A; Brosch R; Manganelli R
    Curr Pharm Des; 2014; 20(27):4346-56. PubMed ID: 24245757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antagonistic transcription factors, EspM and EspN, regulate the ESX-1 secretion system in
    Nicholson KR; Cronin RM; Prest RJ; Menon AR; Yang Y; Jennisch MK; Champion MM; Tobin DM; Champion PA
    mBio; 2024 Apr; 15(4):e0335723. PubMed ID: 38445877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The plasmid-mediated evolution of the mycobacterial ESX (Type VII) secretion systems.
    Newton-Foot M; Warren RM; Sampson SL; van Helden PD; Gey van Pittius NC
    BMC Evol Biol; 2016 Mar; 16():62. PubMed ID: 26979252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstitution of a minimal ESX-5 type VII secretion system suggests a role for PPE proteins in the outer membrane transport of proteins.
    Bunduc CM; Ding Y; Kuijl C; Marlovits TC; Bitter W; Houben ENG
    mSphere; 2023 Oct; 8(5):e0040223. PubMed ID: 37747201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling Tubercular ESX-1 Secretion Using Mycobacterium marinum.
    Chirakos AE; Balaram A; Conrad W; Champion PA
    Microbiol Mol Biol Rev; 2020 Nov; 84(4):. PubMed ID: 32878966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ESX/type VII secretion systems of mycobacteria: Insights into evolution, pathogenicity and protection.
    Simeone R; Bottai D; Frigui W; Majlessi L; Brosch R
    Tuberculosis (Edinb); 2015 Jun; 95 Suppl 1():S150-4. PubMed ID: 25732627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress on the function of Mycobacterium T7SS (ESX) secretion system.
    Jiang ZY; Xie JP
    Yi Chuan; 2023 Dec; 45(12):1100-1113. PubMed ID: 38764274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a substrate domain that determines system specificity in mycobacterial type VII secretion systems.
    Phan TH; Ummels R; Bitter W; Houben EN
    Sci Rep; 2017 Feb; 7():42704. PubMed ID: 28205541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infect and Inject: How
    Tiwari S; Casey R; Goulding CW; Hingley-Wilson S; Jacobs WR
    Microbiol Spectr; 2019 May; 7(3):. PubMed ID: 31172908
    [No Abstract]   [Full Text] [Related]  

  • 15. Mycobacterial Virulence Factors: Surface-Exposed Lipids and Secreted Proteins.
    Ly A; Liu J
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32498243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential Role of the ESX-5 Secretion System in Outer Membrane Permeability of Pathogenic Mycobacteria.
    Ates LS; Ummels R; Commandeur S; van de Weerd R; Sparrius M; Weerdenburg E; Alber M; Kalscheuer R; Piersma SR; Abdallah AM; Abd El Ghany M; Abdel-Haleem AM; Pain A; Jiménez CR; Bitter W; Houben EN
    PLoS Genet; 2015 May; 11(5):e1005190. PubMed ID: 25938982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modular Organization of the ESX-5 Secretion System in Mycobacterium tuberculosis.
    Shah S; Briken V
    Front Cell Infect Microbiol; 2016; 6():49. PubMed ID: 27200304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C terminus of the mycobacterium ESX-1 secretion system substrate ESAT-6 is required for phagosomal membrane damage and virulence.
    Osman MM; Shanahan JK; Chu F; Takaki KK; Pinckert ML; Pagán AJ; Brosch R; Conrad WH; Ramakrishnan L
    Proc Natl Acad Sci U S A; 2022 Mar; 119(11):e2122161119. PubMed ID: 35271388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycosins of the Mycobacterial Type VII ESX Secretion System: the Glue That Holds the Party Together.
    Chen JM
    mBio; 2016 Dec; 7(6):. PubMed ID: 27965454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ESX secretion systems: mycobacterial evolution to counter host immunity.
    Gröschel MI; Sayes F; Simeone R; Majlessi L; Brosch R
    Nat Rev Microbiol; 2016 Nov; 14(11):677-691. PubMed ID: 27665717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.